What is the role of protamine in the treatment of hereditary and acquired hypercoagulability?

Updated: Jan 05, 2018
  • Author: Paul Schick, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print

Protamine has limited ability to reverse bleeding due to LMWH. Reversal agents such as low molecular weight protamines [51] and cationic concatemeric peptides [52] are under investigation but have not yet entered clinical use.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!